Neuraxis receives FDA clearance for PENFS device and expands at-the-market offering
PositiveFinancial Markets

Neuraxis has received FDA clearance for its innovative PENFS device, marking a significant milestone in the medical device industry. This approval not only enhances Neuraxis's product offerings but also reflects the company's commitment to advancing healthcare technology. The PENFS device is expected to improve patient outcomes and streamline medical procedures, making it a noteworthy development for both healthcare providers and patients alike.
— Curated by the World Pulse Now AI Editorial System












